Lipopolysaccharide and a social stressor influence behaviour, corticosterone and cytokine levels: Divergent actions in cyclooxygenase-2 deficient mice and wild type controls

Journal of Neuroimmunology

Volumn 197, Issue 1, 2008, Pages 29-36

  Hayley, Shawn ^a   Mangano, Emily ^a   Strickland, Michael ^a   Anisman, Hymie ^a  

^a CARLETON UNIVERSITY   (Canada)

Author keywords

COX 2; Cytokine; Endotoxin; Interleukin; Stress

Indexed keywords

CORTICOSTERONE; CYCLOOXYGENASE 2; CYTOKINE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIORAL STRESS; CAGE; CONTROL GROUP; CONTROLLED STUDY; DRUG INHIBITION; KNOCKOUT MOUSE; MALE; MENTAL STRESS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOCIAL STRESS; WILD TYPE;

ANIMALS; BEHAVIOR, ANIMAL; CORTICOSTERONE; CYCLOOXYGENASE 2; CYTOKINES; HOUSING, ANIMAL; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; SOCIAL ISOLATION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 44649187454     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.03.015     Document Type: Article

References (63)

1. Aguilera G. Corticotropin releasing hormone, receptor regulation and the stress response. TEM 9 (1998) 329-336
2. Anisman H., Hayley S., Kelly O., Borowski T.B., and Merali Z. Psychogenic, neurogenic and systemic stressor effects on plasma corticosterone and behavior: mouse strain-dependent outcomes. Behav. Neurosci. 115 (2001) 443-454
3. Anisman H., Merali Z., Poulter M.O., and Hayley S. Cytokines as a precipitant of depressive illness: animal and human studies. Curr. Pharm. Des. 11 (2005) 963-972
4. Anisman H., Poulter M.O., Gandhi R., Merali Z., and Hayley S. Interferon-α effects are exaggerated when administered on a psychosocial stressor backdrop: cytokine, corticosterone and brain monoamine variations. J. Neuroimmunol. 186 (2007) 45-53
5. Bale T., and Vale W. CRF and CRF receptors: Role in stress responsivity and other behaviours. Annu. Rev. Pharmacol. Toxicol. 44 (2004) 525-557
6. Barber A.E., Coyle S.M., Marano M.A., Fischer E., Calvano S.E., Fong Y., Moldawer L.L., and Lowry S.F. Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J. Immunol. 150 (1993) 1999-2006
7. Blais V., and Rivest S. Inhibitory action of nitric oxide on circulating tumor necrosis factor-induced NF-kappaB activity and COX-2 transcription in the endothelium of the brain capillaries. J. Neuropathol. Exp. Neurol. 60 (2001) 893-905
8. Blais V., Turrin N.P., and Rivest S. Cycloxygenase 2 (COX-2) inhibition increases the inflammatory response in the brain during systemic immune stimuli. J. Neurochem. 95 (2005) 1563-1574
9. Bosetti F., Langenbach R., and Weerasinghe G.R. Prostaglandin E2 and microsomal prostaglandin E synthase-2 expression are decreased in the cyclooxygenase-2-deficient mouse brain despite compensatory induction of cyclooxygenase-1 and Ca2+-dependent phospholipase A2. J. Neurochem. 91 (2004) 1389-1397
10. Bugajski J., Gadek-Michalska A., and Bugajski A.J. Effect of cyclooxygenase inhibitors on the CRH-induced pituitary-adrenocortical activity during crowding stress. J. Physiol. Pharmacol. 54 (2003) 99-108
11. Carey M.A., Bradbury J.A., Seubert J.M., Langenbach R., Zeldin D.C., and Germolec D.R. Contrasting effects of cyclooxygenase-1 (COX-1) and COX-2 deficiency on the host response to influenza A viral infection. J. Immunol. 175 (2005) 6878-6884
12. Cernak I., O'Connor C., and Vink R. Inhibition of cyclooxygenase 2 by nimesulide improves cognitive outcome more than motor outcome following diffuse traumatic brain injury in rats. Exp. Brain Res. 147 (2002) 193-199
13. Chen G., McCuskey R.S., and Reichlin S. Blood interleukin-6 and tumor necrosis factor-alpha elevation after intracerebroventricular injection of Escherichia coli endotoxin in the rat is determined by two opposing factors: peripheral induction by LPS transferred from brain to blood and inhibition of peripheral response by a brain-mediated mechanism. Neuroimmunomodulation 8 (2000) 59-69
14. Choudhury G. Linear signal transduction pathway involving phosphatidylinositol 3-kinase, protein kinase Cepsilon and MAPK in mesangial cells regulates IFN-γ-induced STAT1α transcriptional activation. J. Biol. Chem. 279 (2004) 27399-27409
15. Cover P.O., Slater D., and Buckingham J.C. Expression of cyclooxygenase enzymes in rat hypothalamo-pituitary-adrenal axis: effects of endotoxin and glucocorticoids. Endocrinology 16 (2001) 123-131
16. Dantzer R., Gheusi G., Johnson R.W., and Kelley K.W. Central administration of insulin-like growth factor-1 inhibits lipopolysaccharide-induced sickness behavior in mice. NeuroReport 10 (1999) 289-292
17. de Meira Santos L.M., Braga Reksidler A., Marques Zanata S., Machado B.H., Tufik S., and Vital M.A. Different Parkinsonism models produce a time-dependent induction of COX-2 in the substantia nigra of rats. Brain Res. 1101 (2006) 117-125
18. Deak T., Bellamy C., and Bordner K. Protracted increases in core body temperature and IL-1 following acute administration of LPS: implications for the stress response. Physiol. Behav. 85 (2005) 296-307
19. Dhir A., Padi S.S., Naidu P.S., and Kulkarni S.K. Protective effect of naproxen (non-selective COX-inhibitor) or rofecoxib (selective COX-2 inhibitor) on immobilization stress-induced behavioral and biochemical alterations in mice. Eur. J. Pharmacol. 535 (2006) 192-198
20. Dronjak S., Gavrilović L., Filipović D., and Radojcić M.B. Immobilization and cold stress affect sympatho-adrenomedullary system and pituitary-adrenocortical axis of rats exposed to long-term isolation and crowding. Physiol. Behav. 81 (2004) 409-415
21. Duman R.S., Nakagawa S., and Malberg J. Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology 25 (2001) 836-844
22. Dunn A.J., Swiergiel A.H., and Palamarchouk V. Brain circuits involved in corticotropin-releasing factor-norepinephrine interactions during stress. Ann. N.Y. Acad. Sci. 1018 (2004) 25-34
23. Dunn A.J., Swiergiel A.H., Zhang H., and Quan N. Reduced ingestion of sweetened milk induced by interleukin-1 and lipopolysaccharide is associated with induction of cyclooxygenase-2 in brain endothelia. Neuroimmunomodulation 13 (2006) 96-104
24. Gadek-Michalska A., and Bugajski J. Role of prostaglandins and nitric oxide in the lipopolysaccharide-induced ACTH and corticosterone response. J. Physiol. Pharmacol. 55 (2004) 663-675
25. Gandhi R., Hayley S., Gibb J., Merali Z., and Anisman H. Influence of poly I:C on sickness behaviors, plasma cytokines, corticosterone and central monoamine activity: moderation by social stressors. Brain Behav. Immun. 21 (2007) 477-489
26. Gibb J., Hayley S., Gandhi R., Poulter M.O., and Anisman H. Synergistic and additive actions of a psychosocial stressor and endotoxin challenge: circulating and brain cytokines, plasma corticosterone and behavioral changes in mice. Brain Behav. Immun. 22 (2008) 573-589
27. Harris S.G., Padilla J., Koumas L., Ray D., and Phipps R.P. Prostaglandins as modulators of immunity. Trends. Immunol. 23 (2002) 144-150
28. Hayley S., and Anisman H. Multiple mechanisms of cytokine action in neurodegenerative and psychiatric states: neurochemical and molecular substrates. Curr. Pharm. Des. 11 (2005) 947-962
29. Hayley S., Merali Z., and Anisman H. Central monoamine activity in genetically distinct strains of mice following a psychogenic stressor: effects of predator exposure. Brain. Res. 892 (2001) 293-300
30. Hayley S., Crocker S.J., Smith P., Shree T., Jackson-Lewis V., Przedborski S., Mount M., Slack R., Anisman H., and Park D.S. Mice lacking the tumor necrosis factor-α or Fas receptors are resistant to MPTP induced death of dopaminergic neurons. J. Neurosci. 24 (2004) 2045-2053
31. Hayley S., Poulter M.O., Merali Z., and Anisman H. The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity. Neuroscience. 135 (2005) 659-678
32. Herman J.P., and Cullinan W.E. Neurocircuitry of stress: central control of hypothalamo-pituitary-adrenocortical axis. Trends. Neurosci. 20 (1997) 78-84
33. Hinz B. Prostaglandin E(2) upregulates cyclooxygenase-2 expression in lipopolysaccharide-stimulated RAW 264.7 macrophages. Biochem. Biophys. Res. Commun. 272 (2000) 744-748
34. Hinz B. Salicyclate metabolites inhibit cyclooxygenase-2-dependent prostaglandin E(2) synthesis in murine macrophages. Biochem. Biophys. Res. Commun. 274 (2000) 197-202
35. Huang Y., Henry C.J., Dantzer R., Johnson R.W., and Godbout J.P. Exaggerated sickness behavior and brain proinflammatory cytokine expression in aged mice in response to intracerebroventricular lipopolysaccharide. Neurobiol. Aging (2007) May 30; [Electronic publication ahead of print]
36. Isovich E., Mijnster M.J., Flügge G., and Fuchs E. Chronic psychosocial stress reduces the density of dopamine transporters. Eur. J. Neurosci. 12 (2000) 1071-1078
37. Jain N.K., Patil C.S., Kulkarni S.K., and Singh A. Modulatory role of cyclooxygenase inhibitors in aging- and scopolamine or lipopolysaccharide-induced cognitive dysfunction in mice. Behav. Brain Res. 133 (2002) 369-376
38. Johnson P.M., Vogt S.K., Burney M.W., and Muglia L.J. COX-2 inhibition attenuates anorexia during systemic inflammation without impairing cytokine production. Am. J. Physiol. Endocrinol. Metab. 282 (2002) E650-E656
39. Konsman J.P., Luheshi G.N., Bluthé R.M., and Dantzer R. The vagus nerve mediates behavioural depression, but not fever, in response to peripheral immune signals; a functional anatomical analysis. Eur. J. Neurosci. 12 (2000) 4434-4446
40. Kumari B., Kumar A., and Dhir A. Protective effect of non-selective and selective COX-2-inhibitors in acute immobilization stress-induced behavioral and biochemical alterations. Pharmacol. Rep. 59 (2007) 699-707
41. Lacroix S., and Rivest S. Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygenase enzymes (COX-1 and COX-2) in the rat brain. J. Neurochem. 70 (1998) 452-466
42. Li S., Ballou L.R., Morham S.G., and Blatteis C.M. Cyclooxygenase-2 mediates the febrile response of mice to interleukin-1beta. Brain Res. 910 (2001) 163-173
43. Li G.Q., Xia H.H., Chen M.H., Gu Q., Wang J.D., Peng J.Z., Chan A.O., Cho C.H., So H.L., Lam S.K., Hu P.J., Liang Y.J., Lin H.L., Berg D.E., Feng Z.H., Langenbach R., and Wong B.C. Effects of cyclooxygenase-1 and -2 gene disruption on Helicobacter pylori-induced gastric inflammation. J. Infect. Dis. 193 (2006) 1037-1046
44. Madrigal J.L., Moro M.A., Lizasoain I., Lorenzo P., Fernández A.P., Rodrigo J., Boscá L., and Leza J.C. Induction of cyclooxygenase-2 accounts for restraint stress-induced oxidative status in rat brain. Neuropsychopharmacology 28 (2003) 1579-1588
45. Manji H.K., Moore G.J., and Chen G. Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness. Biol. Psychiatry. 48 (2000) 740-754
46. McEwen B.S. Plasticity of the hippocampus: adaptation to chronic stress and allostatic load. Ann. N.Y. Acad. Sci. 933 (2001) 265-277
47. McEwen B.S., and Magarinos A.M. Stress and hippocampal plasticity: implications for the pathophysiology of affective disorders. Hum. Psychopharmacol. 16 (2001) S7-S19
48. Mekaouche M., Siaud P., Givalois L., Barbanel G., Malaval F., Maurel D., Assenmacher I., and Ixart G. Different responses of plasma ACTH and corticosterone and of plasma interleukin-1 beta to single and recurrent endotoxin challenges. J. Leukoc. Biol. 59 (1996) 341-346
49. Müller N., Schwarz M.J., Dehning S., Douhe A., Cerovecki A., Goldstein-Müller B., Spellmann I., Hetzel G., Maino K., Kleindienst N., Möller H.J., Arolt V., and Riedel M. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol. Psychiatry 11 (2006) 680-684
50. Myint A.M., Steinbusch H.W., Goeghegan L., Luchtman D., Kim Y.K., and Leonard B.E. Effect of the COX-2 inhibitor celecoxib on behavioural and immune changes in an olfactory bulbectomised rat model of depression. Neuroimmunomodulation 14 (2007) 65-71
51. Nakamoto N., Higuchi H., Kanamori H., Kurita S., Tada S., Takaishi H., Toda K., Yamada T., Kumagai N., Saito H., and Hibi T. Cyclooxygenase-2 inhibitor and interferon-beta synergistically induce apoptosis in human hepatoma cells in vitro and in vivo. Int. J. Oncol. 29 (2006) 625-635
52. Nakata J., Kondo M., Tamaoki J., Takemiya T., Nohara M., Yamagata K., and Nagai A. Augmentation of allergic inflammation in the airways of cyclooxygenase-2-deficient mice. Respirology 10 (2005) 149-156
53. Pinardi G., Prieto J.C., and Miranda H.F. Analgesic synergism between intrathecal morphine and cyclooxygenase-2 inhibitors in mice. Pharmacol. Biochem. Behav. 82 (2005) 120-124
54. Rivest S., Lacroix S., Vallieres L., Nadeau S., Zhang J., and Laflamme N. How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli. Proc. Soc. Exp. Biol. Med. 223 (2000) 22-38
55. Rummel C., Sachot C., Poole S., and Luheshi G.N. Circulating interleukin-6 induces fever through a STAT3-linked activation of COX-2 in the brain. Am. J. Physiol. 291 (2006) R1316-R1326
56. Sapolsky R.M. Is impaired neurogenesis relevant to the affective symptoms of depression?. Biol. Psychiatry 56 (2004) 137-139
57. Satyanarayana P.S., Jain N.K., Singh S., and Kulkarni S.K. Effect of selective inhibition of cyclooxygenase-2 on lipopolysaccharide-induced hyperalgesia. Inflammopharmacology 12 (2004) 57-68
58. Schulkin J., McEwen B.S., and Gold P.W. Allostasis, amygdala, and anticipatory angst. Neurosci. Biobehav. Rev. 18 (1994) 385-396
59. Tanaka A., Hatazawa R., Takahira Y., Izumi N., Filaretova L., and Takeuchi K. Preconditioning stress prevents cold restraint stress-induced gastric lesions in rats: roles of COX-1, COX-2, and PLA2. Dig. Dis. Sci. 52 (2007) 478-487
60. Teismann P., Tieu K., Choi D.K., Wu D.C., Naini A., Hunot S., Vila M., Jackson-Lewis V., and Przedborski S. Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration. Proc. Natl. Acad. Sci. 100 (2003) 5473-5478
61. Tidey J.W., and Miczek K.A. Social defeat stress selectively alters mesocorticolimbic dopamine release: an in vivo microdialysis study. Brain Res. 721 (1996) 140-149
62. Zhang J., and Rivest S. A functional analysis of EP4 receptor-expressing neurons in mediating the action of prostaglandin E2 within specific nuclei of the brain in response to circulating interleukin-1beta. J. Neurochem. 74 (2000) 2134-2145
63. Zhou D., Shanks N., Riechman S.E., Liang R., Kusnecov A.W., and Rabin B.S. Interleukin 6 modulates interleukin-1- and stress-induced activation of the hypothalamic-pituitary-adrenal axis in male rats. Neuroendocrinology 63 (1996) 227-236